July 7, 2023 Comments Off on New tentative approval for Mylan Labs drug posaconazole Posted in: Tentative Approval [](//www.DrugPatentWatch.com/p/preview/generic-api/posaconazole?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Posaconazole is the ge…
July 7, 2023 Comments Off on New patent expiration for Collegium Pharm drug XTAMPZA ER Posted in: Uncategorized
Annual Drug Patent Expirations for XTAMPZA+ER Xtampza Er is a drug marketed by Collegium Pharm Inc and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for Collegium Pharm drug XTAMPZA ER appeared fir…
